首页> 外文期刊>ACS applied materials & interfaces >Decellularized Liver Matrix-Modified Cryogel Scaffolds as Potential Hepatocyte Carriers in Bioartificial Liver Support Systems and Implantable Liver Constructs
【24h】

Decellularized Liver Matrix-Modified Cryogel Scaffolds as Potential Hepatocyte Carriers in Bioartificial Liver Support Systems and Implantable Liver Constructs

机译:脱细胞肝脏改性冷冻机支架作为生物肝脏支持系统中的潜在肝细胞载体和可植入肝脏构建体

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Recent progress in the use of decellularized organ scaffolds as regenerative matrices for tissue engineering holds great promise in addressing the issue of donor organ shortage. Decellularization preserves the mechanical integrity, composition, and microvasculature critical for zonation of hepatocytes in the liver. Earlier studies have reported the possibility of repopulating decellularized matrices with hepatic cell lines or stem cells to improve liver regeneration. In this work, we study the versatility of the decellularized liver matrix as a substrate coating of three-dimensional cryogel scaffolds. The coated cryogels were analyzed for their ability to maintain hepatic cell growth and functionality in vitro, which was found to be significantly better than the uncoated cryogel scaffolds. The decellularized liver matrix-coated cryogel scaffolds were evaluated for their potential application as a cell-loaded bioreactor for bioartificial liver support and as an implantable liver construct. Extracorporeal connection of the coated cryogel bioreactor to a liver failure model showed improvement in liver function parameters. Additionally, offline clinical evaluation of the bioreactor using patient-derived liver failure plasma showed its efficacy in improving liver failure conditions by approximately 30-60%. Furthermore, implantation of the decellularized matrix-coated cryogel showed complete integration with the native tissue as confirmed by hematoxylin and eosin staining of tissue sections. HepG2 cells and primary human hepatocytes seeded in the coated cryogel scaffolds implanted in the liver failure model maintained functionality in terms of albumin synthesis and cytochrome P450 activity post 2 weeks of implantation. In addition, a 20-60% improvement in liver function parameters was observed post implantation. These results, put together, suggest a possibility of using the decellularized matrix-coated cryogel scaffolds for liver tissue engineering applications.
机译:作为组织工程的再生基质使用脱细胞器官支架的最近进展在解决捐助者器官短缺问题方面具有很大的承诺。脱细胞化保留了肝脏中肝细胞区划的机械完整性,组成和微血管结构。早期的研究报告说,用肝细胞系或干细胞重新拆卸脱细胞矩阵以改善肝再生。在这项工作中,我们研究脱细胞肝脏基质的多功能性作为三维冷冻机支架的基材涂层。分析涂覆的CryoGels以维持肝细胞生长和体外功能的能力,发现该能力明显优于未涂覆的冷冻机支架。评价脱细胞肝基质涂覆的冷冻机支架,其潜在应用作为用于生物肝脏支持的细胞加载的生物反应器,并作为可植入肝脏构建体。涂覆的Cryogel生物反应器对肝功能失效模型的体外连接显示肝功能参数的改善。此外,使用患者衍生的肝功能衰竭血浆的生物反应器的离线临床评估显示其在提高肝衰竭条件下的功效约30-60%。此外,植入脱细胞的基质涂覆的Cryogel的植入显示与由苏木精组织和组织切片的嗜己基染色证实的天然组织完全整合。 Hepg2细胞和原发性人肝细胞在植入肝功能衰竭模型中植入的涂覆的冷冻机支架中,在植入后2周的白蛋白合成和细胞色素P450活性方面保持官能度。此外,植入后肝功能参数的提高20-60%。这些结果组合在一起,表明了使用用于肝组织工程应用的脱细胞基质涂覆的Cryogel支架的可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号